PEOPLE (NTC03447678), a phase II trial to test pembrolizumab as first-line treatment in patients with advanced NSCLC with PD-L1 <50%: a multiomics analysis
Published Online: 2023-06-?
Journal: Journal for ImmunoTherapy of CancerLoading...
Authors: Alessandra Fabbri•Alessandra Laura Giulia Pedrocchi•Andrea Anichini•Andrea Franza•Andrea Spagnoletti•Arsela Prelaj•Claudia Giani•Claudia Proto•Daniele Lorenzini•Filippo De Braud•Francesco Sgambelluri•Francesco Trovo'•Giancarlo Pruneri•Giorgio Trinchieri•Giuseppe Lo Russo•Giuseppe Viscardi•James Dolezal•John McCulloch•Laura Mazzeo•Leonardo Provenzano•Luca Agnelli•Marina Chiara Garassino•Mario Occhipinti•Marta Brambilla•Monica Ganzinelli•Paolo Ambrosini•Rita Leporati•Roberta Mortarini•Roberto Ferrara•Sara Manglaviti•Silvia Brich•Teresa Beninato•Tiziana Triulzi•Tommaso Torelli•Valter Torri•Vanja Miskovic
